KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Stereotaxis (STXS) over the last 17 years, with Q3 2025 value amounting to $2.9 million.

  • Stereotaxis' Other Operating Expenses fell 691.62% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year decrease of 385.4%. This contributed to the annual value of $12.4 million for FY2024, which is 3.23% down from last year.
  • As of Q3 2025, Stereotaxis' Other Operating Expenses stood at $2.9 million, which was down 691.62% from $2.8 million recorded in Q2 2025.
  • Stereotaxis' Other Operating Expenses' 5-year high stood at $3.3 million during Q2 2023, with a 5-year trough of $2.8 million in Q2 2025.
  • Its 5-year average for Other Operating Expenses is $3.0 million, with a median of $3.0 million in 2021.
  • Per our database at Business Quant, Stereotaxis' Other Operating Expenses surged by 1979.94% in 2021 and then tumbled by 1587.4% in 2025.
  • Over the past 5 years, Stereotaxis' Other Operating Expenses (Quarter) stood at $3.0 million in 2021, then decreased by 1.9% to $3.0 million in 2022, then dropped by 6.59% to $2.8 million in 2023, then rose by 4.48% to $2.9 million in 2024, then increased by 0.62% to $2.9 million in 2025.
  • Its Other Operating Expenses stands at $2.9 million for Q3 2025, versus $2.8 million for Q2 2025 and $3.1 million for Q1 2025.